As biomarkers are making their way into clinical trials, researchers and clinicians are facing challenges in modifying trial design and defining the right control population, validating biomarker assays from the biological and analytical perspective, and using biomarker data as a guideline for decision making. The Clinical Biomarkers Summit will address biomarker translation from pre-clinical to clinical studies and a variety of biomarker applications in clinical trials, including patient selection, monitoring clinical efficacy and safety, and clinical pharmacology. The Summit also addresses the bridging gap between the pharmaceutical and diagnostics industries and the potential of pharmacogenomics and pharmacodiagnostics. Specific case studies of leveraging biomarkers in accelerating and streamlining clinical trials will offer you a "state-of-the-field" status report.

Featured Sessions
Biomarkers in Clinical Trial Design 
Clinical Validation of Biomarkers 
Translational Medicine 
Pharmacogenomics and Pharmacodiagnostics 
Clinical Proof-of-Concept Studies 
Biomarker Assay Development and Validation 
Clinical Biomarkers for Go/No-Go Decisions 
Clinical Pharmacology 
Biomarkers for Patient Selection 
Biomarkers to Monitor Response to Therapy 
Clinical Utility of Pharmacodynamic Biomarkers 
Biomarkers in Safety Assessment